Predicine was founded in Silicon Valley, California in 2015.
Focusing on the next-generation liquid biopsy diagnostic technique, we establish an integrated "one-stop-shop" biomarker service platform and conduct big data analysis to enable precision medicine in personalized cancer care and global drug development.
Focusing on the next-generation liquid biopsy diagnostic technique, we establish an integrated "one-stop-shop" biomarker service platform and conduct big data analysis to enable precision medicine in personalized cancer care and global drug development.
Gene RADAR: ctRNA and ctDNA single molecule digital Reading
a patented ctRNA + ctDNA combination blood test
Liquid biopsies, or blood tests to detect molecular biomarkers of cancer cells, have traditionally tested only at patients' circulating DNA level. However, many clinically meaningful cancer mutations exist at both the DNA and RNA level, and some are detectable only at the RNA level. By examining DNA and RNA released by cancer cells into blood vessels simultaneously, Gene RADAR boosts detection sensitivity and specificity for genes of interest.
Product Portfolio
|
Clinical Research Solution
|
Clinical Treatment Solution
|
Health Management Solution
|
|
|
|
|
PrediSeq
For Global Pharmaceutical Customers Accelerate Clinical Trials Support Drug Development Vertical Divider
|
PrediAct
For Patients in China Actionable Targets Precision Guidance For Treatment Vertical Divider
|
PrediScreen
For Global Populations at Risk Early Screening Continue Health Management Vertical Divider
|
Meet Our Core Team
|
|
|
|
News & Events
- December 8-11, 2017 - 2017 ASH Annual Meeting (Atlanta) - Predicine Booth
- September 26-30, 2017 - 2017 CSCO (Chinese Society of Clinical Oncology) Annual Meeting at Xiamen, China - Predicine Satellite Meeting and Booth
- September 8-12, 2017 - 2017 ESMO (European Society for Medical Oncology) Annual Meeting at Madrid, Spain - Predicine Booth
- June 21-23, 2017 — Second Annual Liquid Biopsy Summit (San Francisco) — Predicine Presentation
- June 24, 2017 — BioPacific Conference 2017 (CABS) — Predicine Booth
- June 3, 2017 — Clinical Oncologist Daily "Liquid Biopsy to Accelerate Patient Enrollment in Clinical Trials"
- June 2-6, 2017 — 2017 ASCO Annual Meeting (Chicago) — Predicine Booth, Wine Reception & Predi-Trial Launch
- April 1-5, 2017 — AACR 2017 Annual Meeting (Washington DC) — Predicine Booth, Posters, Reception
- March 25, 2017 — CABS Workshop “Precision Medicine for Oncology and Immunology” — Predicine Talk and Booth
- March 18, 2017 — CABS Workshop “NGS for Cancer and Autoimmune disease” — Predicine Booth
- February 20-22, 2017 — The Molecular Medicine Tri Conference 2017 (San Francisco) — Predicine Talk and Booth
- February 16-18, 2017 — 2017 Genitourinary Cancers Symposium (ASCO-GU) — Predicine Booth and new product release
- February 15, 2017 — GEN Report — Tumor Biomarkers Guide Immunotherapy